Back to results
US 2025/0223286 A1Published application
Immunomodulators, compositions and methods thereof
AssigneeBetta Pharmaceuticals Co., Ltd.
InventorsYiqian WANG, Yao ZHANG, Bang FU, Jiabing WANG, Lieming DING
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
Claims16
A compound of Formula (I), or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug, chelate, non-covalent complex, or solvate thereof,
- Wherein,
- R1 and R2 are each independently selected from halogen, CN, C1-6alkyl, or C1-4 haloalkyl;
- Q is a bond, —NH—, or —(CH2)m—O—;
- Ring A is C5-6 aryl, C5-6 heteroaryl, C4-6cycloalkyl or C4-6heterocycloalkyl, wherein the C5-6 heteroaryl and C4-6heterocycloalkyl optionally comprising 1, 2 or 3 hetero atoms independently selected from N, S, or O;
- or
- Ring A is C8-10 fused bicyclic ring;
- R3 is H, halogen, —(CH2)s—NR4R5, C1-4 alkyl, C1-4 alkoxyl, hydroxyl, oxo, CN, (CH2)q—CONR4R5, —COR4, —NR4R5, —NR4C(═O)NR4R5, —NR4C(═NR4)NR4R5, —S(O)2R4, —S(O)2NR4R5, —S(O)R4, —S(O)NR4R5, C2-6 alkenyl, C2-6alknyl, C1-6haloalkyl, C5- 6 aryl, C5-6 heteroaryl, C3-6cycloalkyl or C3-6heterocycloalkyl, wherein the C5-6 heteroaryl and C3-6heterocycloalkyl optionally comprising 1, 2 or 3 hetero atoms independently selected from N, S, or O;
- the C1-4 alkyl, C1-4 alkoxyl, C2-6 alkenyl, C2-6alknyl, C1-6haloalkyl, C5-6 aryl, C5-6 heteroaryl, C3-6cycloalkyl and C3-6heterocycloalkyl optionally substituted with one or more substitutents independently selected R6 substituents;
- R4 and R5 are each independently selected from H, C1-4 alkyl, or C3-6 cycloalkyl, C3-6 heterocyclyl, the C1-4 alkyl, C3-6 cycloalkyl, or C3-6 heterocyclyl optionally substituted with one or more substitutents independently selected R6 substituents;
- or
- R4 and R5 together with the atoms to which they are attached form a 4-10-member heterocyclic ring optionally substituted with one or more substituents independently selected R6 substituents;
- R6 is H, halogen, hydroxyl, oxo, CN, —(CH2)k—NR7R8, —COR7, —NR7R8, —NR7C(═O)NR7R8, —NR7C(═NR7)NR7R8, —S(O)2R7, —S(O)2NR7R8, —S(O)R7, —S(O)NR7R8, or R6 is selected from substituted or unsubstituted C1-4 alkyl, C1-4 alkoxyl, C2-6 alkenyl, C2-6 alknyl, C1-6haloalkyl, C5-6 aryl, C5-6 heteroaryl, C3-10 heterocyclic ring, wherein the C5-6 heteroaryl and C3-10 heterocyclic ring optionally comprising 1, 2 or 3 hetero atoms independently selected from N, S, or O;
- R7 and R8 are each independently selected from H, halogen, hydroxyl, oxo, CN, —S(O)2—C1-4 alkyl, —NH2, —NH—C1-4 alkyl, —(CH2)—N(C1-4 alkyl)2, or R7 and R8 are each independently selected from substituted or unsubstituted C1-4 alkyl, C1-4 alkoxyl, C2-6 alkenyl, C2-6alknyl, C1-6haloalkyl, C5-6 aryl, C5-6 heteroaryl, C3-6cycloalkyl, C3-6heterocycloalkyl;
- wherein the C5-6 heteroaryl and C3-6heterocycloalkyl optionally comprising 1, 2 or 3 hetero atoms independently selected from N, S, or O;
- m, n, q, k and s are each independently selected from 0, 1, 2, 3 or 4.
12 more elements
Dependencies are inferred from the claim text.